I-131-1095 radioligand
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-131-1095 radioligand, covering 2025-10-14 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). [Phase 2]